These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4664535)

  • 1. [Treatment of Hodgkin's disease by segmental radiotherapy extended above and below the diaphragm].
    Kahn A; Laugier A; Zittoun R; Bernadou A; Bilski-Pasquier G; Bousser J
    Ann Med Interne (Paris); 1972 Dec; 123(12):1005-18. PubMed ID: 4664535
    [No Abstract]   [Full Text] [Related]  

  • 2. Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's Lymphoma Study Group.
    Engert A; Schiller P; Josting A; Herrmann R; Koch P; Sieber M; Boissevain F; De Wit M; Mezger J; Duhmke E; Willich N; Muller RP; Schmidt BF; Renner H; Muller-Hermelink HK; Pfistner B; Wolf J; Hasenclever D; Loffler M; Diehl V;
    J Clin Oncol; 2003 Oct; 21(19):3601-8. PubMed ID: 12913100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Radiotherapy of Hodgkin's disease. Factors influencing therapeutic results].
    Roxin T; Geib R
    Strahlentherapie; 1972 Jan; 143(1):33-40. PubMed ID: 4625856
    [No Abstract]   [Full Text] [Related]  

  • 4. [Radiotherapy of Hodgkin's disease. Results of radical megavolt therapy with large fields in comparison with conventional orthovolt therapy. 1. Results of Freiburg patients from 1948 to 1964 and from 1964 to 1969].
    Musshoff K; Kalkoff P; Strickstrock KH; Böhmert A; Mayer W; Merten D
    Strahlentherapie; 1971 Apr; 141(4):381-9. PubMed ID: 5557111
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparison of preliminary results of involved-field with extended field radiotherapy combined with chemotherapy for early stage Hodgkin's disease].
    Wang WH; Li YX; Song YW; Jin J; Liu YP; Wang SL; Zhou LQ; Liu XF; Yu ZH; Han JZ
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):218-21. PubMed ID: 16875611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of splenectomy and radiotherapy on lymphocytes in Hodgkin's disease.
    Sutherland RM; McCredie JA; Inch WR
    Clin Oncol; 1975 Dec; 1(4):275-84. PubMed ID: 1082407
    [No Abstract]   [Full Text] [Related]  

  • 7. Hodgkin's disease. Results from a program in radiation therapy.
    Micaily B; Brady LW
    Am J Clin Oncol; 1984 Apr; 7(2):159-71. PubMed ID: 6422736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of radiotherapy in Hodgkin's disease (1958-1968)].
    Pemsel HK; Hess F; Buchelt L; Pfab R
    Strahlentherapie; 1973 Sep; 146(3):251-8. PubMed ID: 4778515
    [No Abstract]   [Full Text] [Related]  

  • 9. Leukopenia prognosis during radiation therapy in patients with Hodgkin's disease.
    Ivanov SD; Korytova LI; Yamshanov VA; Ilyin NV; Sibirtsev VS
    J Exp Clin Cancer Res; 1997 Dec; 16(4):413-8. PubMed ID: 9505215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
    Mjaaland I; Ganser D; Freitag EM; Bohndorf W
    Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current therapy of Hodgkin's disease].
    Teillet F
    Minerva Med; 1968 Dec; 59(100):5584-97. PubMed ID: 5707467
    [No Abstract]   [Full Text] [Related]  

  • 12. CCNU, vinblastine, procarbazine and prednisone (CVPP) with extended-field radiotherapy in the treatment of early unfavorable Hodgkin's disease. A prospective study on behalf of the Gruppo Italiano per lo Studio dei Linfomi (GISL).
    Gobbi PG; Pieresca C; Cavanna L; Corbella F; Vallisa D; Federico M; Formisano R; Carotenuto M; Merli F; Callea V; Angrilli F; Silingardi V
    Haematologica; 1996; 81(6):503-12. PubMed ID: 9009437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognosis of leukopenia at the early stages of radio- and chemotherapy for Hodgkin's disease].
    Ivanov SD
    Vopr Onkol; 2000; 46(2):129-35. PubMed ID: 10853408
    [No Abstract]   [Full Text] [Related]  

  • 14. [On telecobalt irradiation of malignant lymphomas (Hodgkin's disease, lymphoreticulosarcoma) based on 1000 patients].
    Gyenes G
    Radiobiol Radiother (Berl); 1967; 8(4):401-11. PubMed ID: 4882935
    [No Abstract]   [Full Text] [Related]  

  • 15. [Limitations of radiotherapy in the reticular forms of Hodgkin's disease].
    Lagarde C; Touchard J; Chauvergne J; Hoerni B
    J Radiol Electrol Med Nucl; 1971; 52(3):153-5. PubMed ID: 5577557
    [No Abstract]   [Full Text] [Related]  

  • 16. Low-dose involved-field radiotherapy as alternative treatment of nodular lymphocyte predominance Hodgkin's lymphoma.
    Haas RL; Girinsky T; Aleman BM; Henry-Amar M; de Boer JP; de Jong D
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1199-202. PubMed ID: 19131186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hodgkin's disease: survival and relapse-free data.
    Smithers DW
    Natl Cancer Inst Monogr; 1973 May; 36():509-12. PubMed ID: 4744606
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of clinical stages I and II of Hodgkin's disease].
    Tubiana M; Mathé G; Hayat M; le Bourgeois JP; Henry-Amar M; Laugier A
    Nouv Rev Fr Hematol Blood Cells; 1977; 18(2):463-72. PubMed ID: 917835
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term follow-up of salvage radiotherapy in Hodgkin's lymphoma after chemotherapy failure.
    Campbell B; Wirth A; Milner A; Di Iulio J; MacManus M; Ryan G
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1538-45. PubMed ID: 16125872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended radiotherapy in advanced Hodgkin's disease. Hematologic aspects.
    Johnson RE; Foley HT; Steckel RJ; Glenn DW
    Arch Intern Med; 1966 Jul; 118(1):70-4. PubMed ID: 5940198
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.